Technology News and Research

RSS

arGEN-X generates potent antibody antagonists of Nav1.7 using SIMPLE Antibody technology

arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody™ technology.

12 Sep 2013

Genomatix adds Genomatix Pathway System to Illumina's BaseSpace Apps

Genomatix today announced it has added the Genomatix Pathway System (GePS) to BaseSpace Apps, Illumina's dedicated applications store and informatics community dedicated to advancing genomic analysis.

12 Sep 2013

T-rays are ideal for detecting early signs of melanoma

The technology that peeks underneath clothing at airport security screening check points has great potential for looking underneath human skin to diagnose cancer at its earliest and most treatable stages, a scientist said here today.

12 Sep 2013

New research explains how DNA strands repair themselves

Researchers have discovered the details of how cells repair breaks in both strands of their DNA, a potentially devastating kind of DNA damage.

12 Sep 2013

Telephone delivered program improves health outcomes for people diagnosed with bowel cancer

They say a phone call can change your life and for colorectal or bowel cancer survivors this is true, a new study by a QUT researcher has found.

12 Sep 2013

Researchers develop innovative system to test how virus interacts with cells in body

Researchers at The Mount Sinai Medical Center have developed an innovative system to test how a virus interacts with cells in the body — to see, for example, what happens in lung cells when a deadly respiratory virus attacks them.

12 Sep 2013

Federal officials, contractors give health exchange 'data hub' thumbs up

Several contractors gave positive reports about their readiness to launch the health law's new online marketplaces Oct. 1 at a House hearing Tuesday, although one expert predicted a "rocky start," and several Republicans said they were not reassured.

12 Sep 2013

Kiadis five-year follow-up phase I/II clinical study confirms long-term safety, efficacy of ATIR

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that the five-year follow-up of patients with high-risk malignancies from its Phase I/II clinical study confirms long-term safety and efficacy of ATIR™ over a broad dose range.

12 Sep 2013

Genia Technologies receives $5M grant from NIH to develop nanopore-based DNA sequencing platform

Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies – The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH).

12 Sep 2013

New filtering system may one day help remove carbon dioxide from smokestacks

The amazingly efficient lungs of birds and the swim bladders of fish have become the inspiration for a new filtering system to remove carbon dioxide from electric power station smokestacks before the main greenhouse gas can billow into the atmosphere and contribute to global climate change.

12 Sep 2013

Berg receives Drug Discovery Technology Innovation Award for agnostic approach to drug discovery

Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach, was recognized today with the 2013 North American Drug Discovery Technology Innovation Award at the Frost & Sullivan Growth, Innovation and Leadership Awards Gala, the annual event by the global research organization that highlights the most promising new innovative technology across sectors.

12 Sep 2013

New technique provides better understanding of factors causing Smith-Lemli-Opitz Syndrome

The first proteomic analysis of an animal model of a rare, sometimes deadly birth defect, Smith-Lemli-Opitz Syndrome (SLOS), has revealed that the molecular mechanisms that cause it are more complex than previously understood.

12 Sep 2013

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

...

11 Sep 2013

Hedgepath, Mayne Repurposing Fungal Infection Drug For Cancer

...

11 Sep 2013

Elsevier collaborates with EI in organizing first Energy Systems conference to be held on June 2014, London

Elsevier, a world-leading provider of scientific, technical, and medical information products and services, today announced its official collaboration with the Energy Institute (EI) in organizing the first Energy Systems conference to be held 24-25 June 2014 in London.

11 Sep 2013

Perkins+Will completes UF's Clinical and Translational Research Building

The Miami office of global architecture and design firm, Perkins+Will, recently completed a major healthcare, education and research project, the University of Florida's Clinical and Translational Research Building.

11 Sep 2013

First Edition: September 11, 2013

Today's headlines include reports that some House GOP lawmakers are taking a hard line against funding for the health law in the ongoing debate about raising the nation's debt limit.

11 Sep 2013

Developing Analytical Techniques for Biotherapeutics

News-Medical talks to Dr. Lewis about the development of analytical equipment for a new era of drug development that goes beyond small molecule synthesis.

From Malvern Panalytical 11 Sep 2013

Strides therapeutic approach helps autistic children reach breakthroughs in communication

Luke, a 7-year-old autistic child had primarily only expressed requests to his parents (e.g., I want a drink), but this past year he was given a 1-pound iPad, introduced to a 1,000 pound horse and a special program called Strides©.

11 Sep 2013

Study shows huge cost implications in getting injured patients to appropriate trauma hospitals

During a three-year period in seven metropolitan areas in the western United States, the emergency medical services system sent more than 85,000 injured patients to major trauma hospitals who didn't need to go there - costing the health care system more than $130 million per year, according to an Oregon Health & Science University study published today in the journal Health Affairs.

11 Sep 2013

Technology News and Research

arGEN-X generates potent antibody antagonists of Nav1.7 using SIMPLE Antibody technology

Genomatix adds Genomatix Pathway System to Illumina's BaseSpace Apps

T-rays are ideal for detecting early signs of melanoma

New research explains how DNA strands repair themselves

Telephone delivered program improves health outcomes for people diagnosed with bowel cancer

Researchers develop innovative system to test how virus interacts with cells in body

Federal officials, contractors give health exchange 'data hub' thumbs up

Kiadis five-year follow-up phase I/II clinical study confirms long-term safety, efficacy of ATIR

Genia Technologies receives $5M grant from NIH to develop nanopore-based DNA sequencing platform

New filtering system may one day help remove carbon dioxide from smokestacks

Berg receives Drug Discovery Technology Innovation Award for agnostic approach to drug discovery

New technique provides better understanding of factors causing Smith-Lemli-Opitz Syndrome

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

Hedgepath, Mayne Repurposing Fungal Infection Drug For Cancer

Elsevier collaborates with EI in organizing first Energy Systems conference to be held on June 2014, London

Perkins+Will completes UF's Clinical and Translational Research Building

First Edition: September 11, 2013

Developing Analytical Techniques for Biotherapeutics

Strides therapeutic approach helps autistic children reach breakthroughs in communication

Study shows huge cost implications in getting injured patients to appropriate trauma hospitals

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News